|Bid||4.6300 x 0|
|Ask||4.6700 x 0|
|Day's Range||4.4100 - 4.6700|
|52 Week Range||0.1550 - 6.3300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||29.94|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.89|
TORONTO , May 22, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (RIV.V) today announced the promotion of former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the Company, effective immediately. Bruce Linton has transitioned from his role as acting CEO and will continue to provide oversight, deal flow, strategic insight, and opportunities for collaboration and further strategic alignment with Canopy Growth in conjunction with his ongoing role as Chairman of the Canopy Rivers Board of Directors.
TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .
Unicorn cannabis investment company Canopy Rivers Inc (OTC: CNPOF )(CVE:RIV) has invested $1.5 million in Biolumic, creators of a sustainable UV crop yield enhancement system. This is Canopy River’s first ...
TORONTO and PALMERSTON NORTH, New Zealand , May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (RIV.V), (CNPOF) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million , closing the oversubscribed round at US$6.7 million . This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.
SMITHS FALLS, ON, May 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (RIV.V) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing. PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners. Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.
TORONTO , May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (WEED.TO) (CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018 .
TORONTO, May 3, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization.
HOUSTON, TX / ACCESSWIRE / April 30, 2019 / The cannabis beauty market is just beginning to gain momentum. "There is a great deal of room for innovation in his sector, and topicals and beauty products are expected to explode with legalization and the entry of major consumer packaged goods companies," notes market research firm, The Brightfield Group. Some of the top companies benefiting from the news are The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), Canopy Rivers Inc. (TSXV:RIV)(OTC:CNPOF), and Ovation Science Inc. (CSE:OVAT)(OTC:OVATF).
Canopy Growth Corp. is not outright acquiring Acreage Holdings Inc., as reports said Wednesday, but it is preparing to pay billions for the rights to buy the U.S.-based pot company.
TORONTO, April 16, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (RIV.V) and High Beauty, Inc. ("High Beauty") are pleased to announce the completion of an investment by Canopy Rivers in High Beauty, creator of industry-leading cannabis beauty brand high. Canopy Rivers has subscribed for US$2.5 million of shares in High Beauty, representing 18.4% of the company on a fully diluted basis, including additional warrant coverage. "Being supported by Canopy Rivers enables us to collaborate within the Canopy Rivers ecosystem and to focus our energy and passion on the creation of a robust new product line using cannabis-derived extracts," said Melissa Jochim, a highly successful formulator and Founder of High Beauty.
TORONTO , April 1, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF), has received its cultivation licence from Health Canada for its Kitchener-based commercial scale production facility ("JWC2"). This second licence launches the initial phase of JWC2, a 345,000 square foot production and distribution complex where JWC is rolling out more than 130 individual production rooms utilizing JWC's proprietary GrowthSTORM™ Dual Droplet cultivation platform and methodologies.
Canopy Rivers Inc (OTCMKTS:CNPOF) has announced that it was awarded a cannabis growth license for both Canopy Growth Corp (NYSE:CGC) and also its portfolio firm called Spot Therapeutics. The Health Canada cultivation license will facilitate production and distribution of cannabis at Canopy’s facility in Fredericton. The announcement also revealed that the license will allow the […]The post Canopy Rivers Secures Cannabis Growth License From Health Canada appeared first on Market Exclusive.
Investorideas.com, a leading investor news resource covering tech and cannabis stocks, releases a snapshot looking at how payment technology and data solutions have evolved due to the regulatory hurdles facing the cannabis industry. PaymentsJournal discussed the “cannabis payments conundrum” and how as the cannabis industry matures we are beginning to see an evolution in payment and data tech companies. From the article: “The next few years will be hugely important in bringing more validity to the cannabis industry as it continues to expand into new legalized markets.
Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (RIV.V) congratulates Canopy Growth Corporation (WEED.TO) (CGC) (“Canopy Growth”) and its portfolio company, Spot Therapeutics Inc. (“Spot”), on receiving a cultivation license from Health Canada for its Fredericton-based production and distribution facility. In 2017, Canopy Growth solidified its expansion strategy in Atlantic Canada when it acquired Spot and made significant local funding commitments in collaboration with Canopy Rivers, ultimately resulting in Canopy Growth being rewarded with one of the first provincial supply contracts in the cannabis industry, pursuant to a landmark MOU with the government of New Brunswick.
SMITHS FALLS , ON and FREDERICTON, NB , March 25, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED), (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has received a cultivation licence from Health Canada for its facility in Fredericton, New Brunswick . With this licensing, Canopy Growth predicts the facility will initially produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months. Developed in collaboration with Canopy Rivers Inc. (RIV.V) and operating under Canopy Growth's flagship Tweed brand, the facility will support the Company's global and local operations with high quality, large-scale cannabis production capabilities that will serve the needs of recreational and medical customers.
Following Canada's country-wide legalization back in October 2018, the cannabis industry has used the momentum gained from Canada's legislation to demonstrate, on a global scale, the economic benefits of investing in cannabis companies. Leafbuyer Technologies Inc (OTC:LBUY), Acreage Holdings Inc (ACRGF), Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V), The Yield Growth Corp (OTCQB:BOSQF) represent 4 marijuana stocks leading the industry on Wednesday. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.